Fertility and Sterility/LinkedIn
Oct 12, 2025, 07:57
Relugolix Combo Therapy in Fibroids and Adenomyosis – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn about a paper by William H. Catherino et al. published in Fertility and Sterility:
“Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: Subgroup analysis of LIBERTY 1 and LIBERTY 2
Title: Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Authors: William H. Catherino, Ayman Al-Hendy, Souhil Zaim, Nadia Bouzegaou, Roberta Venturella, Elizabeth A. Stewart, Rui Wu, Silvia Vannuccini, Julie S. Perry, Viatcheslav G. Rakov, Malcolm G. Munro
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now